HNI's announcement that it will acquire Steelcase in a $2.2 billion cash-and-stock deal has catalyzed intense debate among investors and industry watchers ...

Y-mAbs Therapeutics stunned investors when SERB Pharmaceuticals announced an all-cash bid to take the company private at $8.60 per share, valuing the deal at approximately ...

The latest Consumer Price Index (CPI) report for July has painted a mixed picture for inflation, with consumer prices rising, but not at the rate ...

As Palantir’s stock has climbed over 600% in the past year, its LTM EV/ Revenue multiple stands at 118x which demands scrutiny against concentration risks, ...